Cite
Gougeon ML, Poirier-Beaudouin B, Durant J, et al. HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND). Heliyon. 2017;3(2):e00245doi: 10.1016/j.heliyon.2017.e00245.
Gougeon, M. L., Poirier-Beaudouin, B., Durant, J., Lebrun-Frenay, C., Saïdi, H., Seffer, V., Ticchioni, M., Chanalet, S., Carsenti, H., Harvey-Langton, A., Laffon, M., Cottalorda, J., Pradier, C., Dellamonica, P., & Vassallo, M. (2017). HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND). Heliyon, 3(2), e00245. https://doi.org/10.1016/j.heliyon.2017.e00245
Gougeon, Marie-Lise, et al. "HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND)." Heliyon vol. 3,2 (2017): e00245. doi: https://doi.org/10.1016/j.heliyon.2017.e00245
Gougeon ML, Poirier-Beaudouin B, Durant J, Lebrun-Frenay C, Saïdi H, Seffer V, Ticchioni M, Chanalet S, Carsenti H, Harvey-Langton A, Laffon M, Cottalorda J, Pradier C, Dellamonica P, Vassallo M. HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND). Heliyon. 2017 Feb 13;3(2):e00245. doi: 10.1016/j.heliyon.2017.e00245. eCollection 2017 Feb. PMID: 28224137; PMCID: PMC5310155.
Copy
Download .nbib